Bronchial Fistula: Rare Complication of Treatment with Anlotinib

BACKGROUND AND OBJECTIVE: Anlotinib is a newly developed small molecule multiple receptor tyrosine kinase (RTK) inhibitor that was approved for the treatment of patients with lung cancer in China. We aim to report 3 cases of rare complication of anlotinib-bronchial fistula (BF) during the treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: DENG, Pengbo, HU, Chengping, LI, Yuanyuan, CAO, Liming, YANG, Huaping, LI, Min, AN, Jian, JIANG, Juan, GU, Qihua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 中国肺癌杂志编辑部 2020
Materias:
Clinical Experience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7583880/
https://www.ncbi.nlm.nih.gov/pubmed/32987493
http://dx.doi.org/10.3779/j.issn.1009-3419.2020.102.40

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7583880/
https://www.ncbi.nlm.nih.gov/pubmed/32987493
http://dx.doi.org/10.3779/j.issn.1009-3419.2020.102.40

Ejemplares similares